Who owns CONMED Corp (CNMD)? Elite investor 13F holders
3 tracked elite investors reported holding CONMED Corp as of 2026-09-30, including Oaktree Capital Management, D.E. Shaw, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Health Care Equipment & Services
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oaktree Capital Management | CONMED CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 52464810.00 USD | 53645000.000000 | Principal | add | Original filing |
| D.E. Shaw | CONMED CORP | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 5909904.00 USD | 127837.000000 | Shares | add | Original filing |
| GAMCO | CONMED CORP | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 2644356.00 USD | 57200.000000 | Shares | hold | Original filing |
| Gotham Asset Management | CONMED CORP | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.